← Back to catalogue

Ablacon™ Mapping Catheter

FDA UDI

Class II (US FDA UDI)

by Ablacon Inc.

Identity

Trade Name
Ablacon™ Mapping Catheter FDA UDI
Generic Name
Cardiac mapping catheter, percutaneous, single-use FDA UDI
Device Name
The Ablacath™ Mapping Catheter may be used to detect electrical potentials from the endocardial surfaces of the heart. These signals may be used for analysis with mapping systems. The Ablacath™ Mapping Catheter may also be used to deliver externally generated pacing stimuli. FDA UDI
Model / Reference
AB-0003-60 FDA UDI
Description
The Ablacath™ Mapping Catheter may be used to detect electrical potentials from the endocardial surfaces of the heart. These signals may be used for analysis with mapping systems. The Ablacath™ Mapping Catheter may also be used to deliver externally generated pacing stimuli. FDA UDI

Identifiers

Primary DI / UDI-DI
00860457001551 FDA UDI
FDA Product Code
MTD FDA UDI
GMDN Term
Cardiac mapping catheter, percutaneous, single-use FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
870.1220 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Cardiac mapping catheter, percutaneous, single-use

Ablacon™ Mapping Catheter by Ablacon Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cardiac mapping catheter, percutaneous, single-use.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Ablacon Inc.

Sources (1)

  • FDA UDI e875a3bd-da60-4bdf-9f12-0b8e6fd441de 35 fields · synced May 30, 2026